Selected research
Market Outlook & Growth Opportunities
Global Amantadine Hydrochloride Market Outlook and Growth Opportunities 2026
Market perspective
The global Amantadine Hydrochloride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Amantadine Hydrochloride market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Amantadine Hydrochloride market include Actavis, Cipla, Hi-Tech Pharma, Pai Pharma, Protec, NE Pharma, Hengshan Pharma, Wantong Pharma and Pengyao Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Amantadine Hydrochloride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Amantadine Hydrochloride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amantadine Hydrochloride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amantadine Hydrochloride market size, projected growth trends, production technologies, key applications, and end-use industries.
Amantadine Hydrochloride Segment by Company
Actavis
Cipla
Hi-Tech Pharma
Pai Pharma
Protec
NE Pharma
Hengshan Pharma
Wantong Pharma
Pengyao Pharma
Purina Biotechnology
SANDOZ
Taiyi Phrama
Sine Phrama
Amantadine Hydrochloride Segment by Type
Tablets
Oral Solution
Amantadine Hydrochloride Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Amantadine Hydrochloride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Amantadine Hydrochloride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Amantadine Hydrochloride market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Amantadine Hydrochloride significant trends, drivers, influence factors in global and regions.
6. To analyze Amantadine Hydrochloride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amantadine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amantadine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amantadine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amantadine Hydrochloride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amantadine Hydrochloride industry.
Chapter 3: Detailed analysis of Amantadine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Amantadine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Amantadine Hydrochloride in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Solution
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Actavis
- Cipla
- Hi-Tech Pharma
- Pai Pharma
- Protec
- NE Pharma
- Hengshan Pharma
- Wantong Pharma
- Pengyao Pharma
- Purina Biotechnology
- SANDOZ
- Taiyi Phrama
- Sine Phrama
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Amantadine Hydrochloride Sales Value (2021-2032)
- 1.2.2 Global Amantadine Hydrochloride Sales Volume (2021-2032)
- 1.2.3 Global Amantadine Hydrochloride Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Amantadine Hydrochloride Market Dynamics
- 2.1 Amantadine Hydrochloride Industry Trends
- 2.2 Amantadine Hydrochloride Industry Drivers
- 2.3 Amantadine Hydrochloride Industry Opportunities and Challenges
- 2.4 Amantadine Hydrochloride Industry Restraints
3 Amantadine Hydrochloride Market by Company
- 3.1 Global Amantadine Hydrochloride Company Revenue Ranking in 2025
- 3.2 Global Amantadine Hydrochloride Revenue by Company (2021-2026)
- 3.3 Global Amantadine Hydrochloride Sales Volume by Company (2021-2026)
- 3.4 Global Amantadine Hydrochloride Average Price by Company (2021-2026)
- 3.5 Global Amantadine Hydrochloride Company Ranking (2024-2026)
- 3.6 Global Amantadine Hydrochloride Company Manufacturing Base and Headquarters
- 3.7 Global Amantadine Hydrochloride Company Product Type and Application
- 3.8 Global Amantadine Hydrochloride Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Amantadine Hydrochloride Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Amantadine Hydrochloride Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Amantadine Hydrochloride Market by Type
- 4.1 Amantadine Hydrochloride Type Introduction
- 4.1.1 Tablets
- 4.1.2 Oral Solution
- 4.2 Global Amantadine Hydrochloride Sales Volume by Type
- 4.2.1 Global Amantadine Hydrochloride Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amantadine Hydrochloride Sales Volume by Type (2021-2032)
- 4.2.3 Global Amantadine Hydrochloride Sales Volume Share by Type (2021-2032)
- 4.3 Global Amantadine Hydrochloride Sales Value by Type
- 4.3.1 Global Amantadine Hydrochloride Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amantadine Hydrochloride Sales Value by Type (2021-2032)
- 4.3.3 Global Amantadine Hydrochloride Sales Value Share by Type (2021-2032)
5 Amantadine Hydrochloride Market by Application
- 5.1 Amantadine Hydrochloride Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Amantadine Hydrochloride Sales Volume by Application
- 5.2.1 Global Amantadine Hydrochloride Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amantadine Hydrochloride Sales Volume by Application (2021-2032)
- 5.2.3 Global Amantadine Hydrochloride Sales Volume Share by Application (2021-2032)
- 5.3 Global Amantadine Hydrochloride Sales Value by Application
- 5.3.1 Global Amantadine Hydrochloride Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amantadine Hydrochloride Sales Value by Application (2021-2032)
- 5.3.3 Global Amantadine Hydrochloride Sales Value Share by Application (2021-2032)
6 Amantadine Hydrochloride Regional Sales and Value Analysis
- 6.1 Global Amantadine Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amantadine Hydrochloride Sales by Region (2021-2032)
- 6.2.1 Global Amantadine Hydrochloride Sales by Region: 2021-2026
- 6.2.2 Global Amantadine Hydrochloride Sales by Region (2027-2032)
- 6.3 Global Amantadine Hydrochloride Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Amantadine Hydrochloride Sales Value by Region (2021-2032)
- 6.4.1 Global Amantadine Hydrochloride Sales Value by Region: 2021-2026
- 6.4.2 Global Amantadine Hydrochloride Sales Value by Region (2027-2032)
- 6.5 Global Amantadine Hydrochloride Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Amantadine Hydrochloride Sales Value (2021-2032)
- 6.6.2 North America Amantadine Hydrochloride Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Amantadine Hydrochloride Sales Value (2021-2032)
- 6.7.2 Europe Amantadine Hydrochloride Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Amantadine Hydrochloride Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Amantadine Hydrochloride Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Amantadine Hydrochloride Sales Value (2021-2032)
- 6.9.2 South America Amantadine Hydrochloride Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Amantadine Hydrochloride Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Amantadine Hydrochloride Sales Value Share by Country, 2025 VS 2032
7 Amantadine Hydrochloride Country-level Sales and Value Analysis
- 7.1 Global Amantadine Hydrochloride Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Amantadine Hydrochloride Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Amantadine Hydrochloride Sales by Country (2021-2032)
- 7.3.1 Global Amantadine Hydrochloride Sales by Country (2021-2026)
- 7.3.2 Global Amantadine Hydrochloride Sales by Country (2027-2032)
- 7.4 Global Amantadine Hydrochloride Sales Value by Country (2021-2032)
- 7.4.1 Global Amantadine Hydrochloride Sales Value by Country (2021-2026)
- 7.4.2 Global Amantadine Hydrochloride Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.9.2 France Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.16.2 China Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.19.2 India Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Amantadine Hydrochloride Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Amantadine Hydrochloride Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Amantadine Hydrochloride Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Actavis
- 8.1.1 Actavis Company Information
- 8.1.2 Actavis Business Overview
- 8.1.3 Actavis Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Actavis Amantadine Hydrochloride Product Portfolio
- 8.1.5 Actavis Recent Developments
- 8.2 Cipla
- 8.2.1 Cipla Company Information
- 8.2.2 Cipla Business Overview
- 8.2.3 Cipla Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Cipla Amantadine Hydrochloride Product Portfolio
- 8.2.5 Cipla Recent Developments
- 8.3 Hi-Tech Pharma
- 8.3.1 Hi-Tech Pharma Company Information
- 8.3.2 Hi-Tech Pharma Business Overview
- 8.3.3 Hi-Tech Pharma Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Hi-Tech Pharma Amantadine Hydrochloride Product Portfolio
- 8.3.5 Hi-Tech Pharma Recent Developments
- 8.4 Pai Pharma
- 8.4.1 Pai Pharma Company Information
- 8.4.2 Pai Pharma Business Overview
- 8.4.3 Pai Pharma Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Pai Pharma Amantadine Hydrochloride Product Portfolio
- 8.4.5 Pai Pharma Recent Developments
- 8.5 Protec
- 8.5.1 Protec Company Information
- 8.5.2 Protec Business Overview
- 8.5.3 Protec Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Protec Amantadine Hydrochloride Product Portfolio
- 8.5.5 Protec Recent Developments
- 8.6 NE Pharma
- 8.6.1 NE Pharma Company Information
- 8.6.2 NE Pharma Business Overview
- 8.6.3 NE Pharma Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.6.4 NE Pharma Amantadine Hydrochloride Product Portfolio
- 8.6.5 NE Pharma Recent Developments
- 8.7 Hengshan Pharma
- 8.7.1 Hengshan Pharma Company Information
- 8.7.2 Hengshan Pharma Business Overview
- 8.7.3 Hengshan Pharma Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Hengshan Pharma Amantadine Hydrochloride Product Portfolio
- 8.7.5 Hengshan Pharma Recent Developments
- 8.8 Wantong Pharma
- 8.8.1 Wantong Pharma Company Information
- 8.8.2 Wantong Pharma Business Overview
- 8.8.3 Wantong Pharma Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Wantong Pharma Amantadine Hydrochloride Product Portfolio
- 8.8.5 Wantong Pharma Recent Developments
- 8.9 Pengyao Pharma
- 8.9.1 Pengyao Pharma Company Information
- 8.9.2 Pengyao Pharma Business Overview
- 8.9.3 Pengyao Pharma Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Pengyao Pharma Amantadine Hydrochloride Product Portfolio
- 8.9.5 Pengyao Pharma Recent Developments
- 8.10 Purina Biotechnology
- 8.10.1 Purina Biotechnology Company Information
- 8.10.2 Purina Biotechnology Business Overview
- 8.10.3 Purina Biotechnology Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Purina Biotechnology Amantadine Hydrochloride Product Portfolio
- 8.10.5 Purina Biotechnology Recent Developments
- 8.11 SANDOZ
- 8.11.1 SANDOZ Company Information
- 8.11.2 SANDOZ Business Overview
- 8.11.3 SANDOZ Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.11.4 SANDOZ Amantadine Hydrochloride Product Portfolio
- 8.11.5 SANDOZ Recent Developments
- 8.12 Taiyi Phrama
- 8.12.1 Taiyi Phrama Company Information
- 8.12.2 Taiyi Phrama Business Overview
- 8.12.3 Taiyi Phrama Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Taiyi Phrama Amantadine Hydrochloride Product Portfolio
- 8.12.5 Taiyi Phrama Recent Developments
- 8.13 Sine Phrama
- 8.13.1 Sine Phrama Company Information
- 8.13.2 Sine Phrama Business Overview
- 8.13.3 Sine Phrama Amantadine Hydrochloride Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Sine Phrama Amantadine Hydrochloride Product Portfolio
- 8.13.5 Sine Phrama Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amantadine Hydrochloride Value Chain Analysis
- 9.1.1 Amantadine Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amantadine Hydrochloride Sales Mode & Process
- 9.2 Amantadine Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amantadine Hydrochloride Distributors
- 9.2.3 Amantadine Hydrochloride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst